Nav: Home

Life data economics: calling for new models to assess the value of human data

June 27, 2019

June 27, 2019 - Recent advances in artificial intelligence and precision medicine led to the emergence of new businesses that trade and process human health data. Most pharmaceutical companies are acquiring large volumes of clinical and other data for research and marketing purposes. However, there are few examples of companies turning this data into new therapeutic products and it is difficult to estimate the potential benefits stemming from a specific data type or a combination. Unlike in finance, where there are established methods for pricing anything from money to complex derivative securities, there are no established models for estimating the value of human life data.

One of the ways to develop the data economics models is to establish a marketplace for human life data where patients can take control of their data and profit from either the direct sale of this data, or share in the profits generated using this data. In the paper titled "The Advent of Human Life Data Economics" in Cell Trends in Molecular Nature, George Church, a professor at Harvard Medical School and the co-founder of Nebula Genomics and Alex Zhavoronkov, the founder of Insilico Medicine present a concept of data economics with the multiple parameters impacting the value of human life data. The paper provides an overview of the blockchain-enabled platforms for exchanging medical records after the burst of the blockchain bubble.

"In addition to these hack-resistant public ledgers, we have rapidly improving tools for whole genome sequencing and homomorphic encryption queries to deliver better privacy so that many people can finally benefit from knowing and owning their own genomes," said George Church, Ph.D., Professor of Genetics at Harvard Medical School and a founding member of the Wyss Institute for Biologically Inspired Engineering at Harvard.

The healthcare industry has increasingly adopted blockchain technologies for life data management to improve the quality, efficiency, and transparency of the health care system. The growth of electronic patient records has led to the artificial intelligence-based data analysis that can provide unprecedented insights into human health. Adopting big data technologies in the healthcare sector carries many benefits, but it also raises some barriers and challenges.

With the continued growth of the blockchain technology within the healthcare system, data security, patient data privacy and the ability to manage consent and share data benefits with the patients, has become more vital than ever. Storing and processing medical data in the cloud, or the closed ecosystem, which prevents its illegal usage, blockchain technology can increase patients' engagement by allowing them to make profit from the initial sale of the data.

"George Church pioneered many areas of science and technology and inspired three generations of scientists in multiple areas. This paper presents a call for new models for valuing human life data with the many proposed parameters. Leading economists and mathematicians are invited to collaborate on data pricing models in the context of human health. When human life data can be considered to be an asset in the context of financial accounting and can be easily traded, we are likely to see an explosion of data-driven biomedical innovation," said Alex Zhavoronkov, Ph.D, Founder and CEO of Insilico Medicine.
-end-
For further information, images or interviews, please contact:

Contact: Klug Gehilfe
ai@pharma.ai

Please follow the link to read the article:

https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(19)30104-2

About Insilico Medicine, Inc

Insilico Medicine is an artificial intelligence company headquartered in Rockville, with R&D and management resources in Belgium, Russia, UK, Taiwan, and Korea sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through excellence in biomarker discovery, drug development, digital medicine, and aging research.

Insilico pioneered the applications of the generative adversarial networks (GANs) and reinforcement learning for generation of novel molecular structures for the diseases with a known target and with no known targets. In addition to working collaborations with the large pharmaceutical companies, the company is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with LifeExtension.com, the company launched a range of nutraceutical products compounded using the advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI.

In 2017, NVIDIA selected Insilico Medicine as one of the Top 5 AI companies in its potential for social impact. In 2018, the company was named one of the global top 100 AI companies by CB Insights. In 2018 it received the Frost & Sullivan Award accompanied with the industry brief. Website: http://insilico.com/

InSilico Medicine, Inc.

Related Technology Articles:

Rethinking the role of technology in the classroom
Introducing tablets and laptops to the classroom has certain educational virtues, according to Annahita Ball, an assistant professor in the University at Buffalo School of Social Work, but her research suggests that tech has its limitations as well.
The science and technology of FAST
The Five hundred-meter Aperture Spherical radio Telescope (FAST), located in a radio quiet zone, with the targets (e.g., radio pulsars and neutron stars, galactic and extragalactic 21-cm HI emission).
AI technology could help protect water supplies
Progress on new artificial intelligence (AI) technology could make monitoring at water treatment plants cheaper and easier and help safeguard public health.
Transformative technology
UC Davis neuroscientists have developed fluorescence sensors that are opening a new era for the optical recording of dopamine activity in the living brain.
Do the elderly want technology to help them take their medication?
Over 65s say they would find technology to help them take their medications helpful, but need the technology to be familiar, accessible and easy to use, according to research by Queen Mary University of London and University of Cambridge.
Technology detecting RNase activity
A KAIST research team of Professor Hyun Gyu Park at Department of Chemical and Biomolecular Engineering developed a new technology to detect the activity of RNase H, a RNA degrading enzyme.
Taking technology to the next level
Physicists from the ARC Centre of Excellence for Ultrahigh bandwidth Devices for Optical Systems (CUDOS) developed a new hybrid integrated platform, promising to be a more advanced alternative to conventional integrated circuits.
How technology use affects at-risk adolescents
More use of technology led to increases in attention, behavior and self-regulation problems over time for adolescents already at risk for mental health issues, a new study from Duke University finds.
Hold-up in ventures for technology transfer
The transfer of technology brings ideas closer to commercialization. The transformation happens in several steps, such as invention, innovation, building prototypes, production, market introduction, market expansion, after sales services.
The ultimate green technology
Imagine patterning and visualizing silicon at the atomic level, something which, if done successfully, will revolutionize the quantum and classical computing industry.
More Technology News and Technology Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#540 Specialize? Or Generalize?
Ever been called a "jack of all trades, master of none"? The world loves to elevate specialists, people who drill deep into a single topic. Those people are great. But there's a place for generalists too, argues David Epstein. Jacks of all trades are often more successful than specialists. And he's got science to back it up. We talk with Epstein about his latest book, "Range: Why Generalists Triumph in a Specialized World".
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.